Understanding fragile X syndrome: insights from animal models
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The fragile X mental retardation syndrome is caused by large methylated expansions of a CGG repeat in the FMR1 gene leading to the loss of expression of FMRP, an RNA-binding protein. FMRP is proposed to act as a regulator of mRNA transport or translation that plays a role in synaptic maturation and function. To study the physiological function of the FMR1 protein, mouse and Drosophila models have been developed. The loss-of-function mouse model shows slightly enlarged testes, a subtle behavioral phenotype, and discrete anomalies of dendrite spines similar to those observed in brains of patients. Studies in Drosophila indicate that FXMR plays an important role in synaptogenesis and axonal arborization, which may underlie the observed deficits in flight ability and circadian behavior of fxr mutant flies. The relevance of these studies to our understanding of fragile X syndrome is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · cited 2×
“…with an unstable expansion of a CGG repeat located in the 5) UTR of the fragile X mental retardation gene (FMR1) followed by an abnormal methylation pattern that most of the time leads to a transcription silencing of the gene (Oberlé et al., 1991; Verkerk et al., 1991; Sutcliffe et al., 1992).”
BackgroundSelf-citationFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080 · cited 1×
“The most common alleles have 29 or 30 triplets (Fu et al., 1991).”
BackgroundSelf-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Self-citationDeficient Hippocampal Long-Term Potentiation in α-Calcium-Calmodulin Kinase II Mutant Mice
Silva, A. J., Stevens, C. F., Tonegawa, S., & Wang, Y. (1992) · Science · doi:10.1126/science.1378648 · Cited by 1,472 · cited 1×
“…Genome Res 100:111–123 (2003) ies on other, unrelated knockout mouse models have shown that also long-term potentiation (LTP) is involved in malperformance of the Morris water maze task (Grant et al., 1992; Silva et al., 1992a, 1992b; Bach et al., 1995; Sakimura et al., 1995; Wu et al., 1995).”
BackgroundExperience and brain development
Greenough, W. T., Black, J. E., & Wallace, C. S. (1987) · Child Development · doi:10.2307/1130197 · Cited by 1,398 · cited 1×
“Polyribosomal aggregates in spines increase during experiencedependent synaptogenesis (Greenough et al., 1987).”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 7×
“…mentioned before, FMRP is expressed in synapses in response to activation of glutamate receptors by glutamate (Weiler et al., 1997; Weiler and Greenough, 1999) and via a negative inhibition pathway FMRP suppresses translation of mRNA (Laggerbauer et al., 2001; Li et al., 2001; Huber et al., 2002).”
BackgroundInfluentialBrown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · cited 4×
“The futsch homologue, MAP-1B, was also recently identified as one of the many targets of FMRP (Brown et al., 2001).”
BackgroundInfluentialAbnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046 · cited 5×
“Anatomical analyses in human, mouse and Drosophila suggest that regulation of dendrite growth and/or synapse formation may be affected (Comery et al., 1997; Zhang et al., 2001; Dockendorff et al., 2002).”
BackgroundInfluentialSelf-citationImportance of AMPA Receptors for Hippocampal Synaptic Plasticity But Not for Spatial Learning
Zamanillo, D., Sprengel, R., Hvalby, Ø., Jensen, V., Burnashev, N., Rozov, A., Kaiser, K. M. M., Köster, H. J., Borchardt, T., Worley, P., et al. (1999) · Science · doi:10.1126/science.284.5421.1805 · Cited by 791 · cited 1×
“For the AMPA receptors, it has recently been found that they have an important function in synaptic plasticity (Musleh et al., 1997; Nayak et al., 1998; Zamanillo et al., 1999).”
BackgroundDNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644 · cited 3×
“As mentioned before, FMRP is expressed in synapses in response to activation of glutamate receptors by glutamate (Weiler et al., 1997; Weiler and Greenough, 1999) and via a negative inhibition pathway FMRP suppresses translation of mRNA (Laggerbauer et al., 2001; Li et al., 2001; Huber et al.,…”
BackgroundThe protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
Siomi, H., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1993) · Cell · doi:10.1016/0092-8674(93)90420-u · Cited by 641
The Dynamics of Dendritic Structure in Developing Hippocampal Slices
Dailey, M. E., & Smith, S. J. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-09-02983.1996 · Cited by 611 · cited 1×
“Spine motility is believed to represent postsynaptic participation in synapse formation (Dailey and Smith, 1996).”
BackgroundImpaired Hippocampal Representation of Space in CA1-Specific NMDAR1 Knockout Mice
McHugh, T. J., Blum, K. I., Tsien, J. Z., Tonegawa, S., & Wilson, M. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81828-0 · Cited by 593 · cited 3×
“LTP is an input-specific and persistent increase in the strength of synaptic connections that is the major model mechanism for information storage in the brain (Bliss and Collingridge, 1993; Danysz et al., 1995; Asztely and Gustafsson, 1996; McHugh et al., 1996; Tsien, 2000; Lu et al., 2001).”
BackgroundEvidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Abnormal Development of Dendritic Spines in FMR1 Knock-Out Mice
Nimchinsky, E. A., Oberlander, A. M., & Svoboda, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05139.2001 · Cited by 560 · cited 10×
“An abnormality in spine motility early in postnatal life could affect synaptogenesis, and therefore it is of interest to determine spine motility in the absence of Fmrp. Nimchinsky et al. (2001) showed that dendrite spines in vivo in the intact brain of Fmr1 knockout mice were abnormal early in postnatal life.”
BackgroundMethodResultInfluentialAnalysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527 · cited 2×
“It may well be that the mouse model does simply not resemble the human disease with respect to brain structure, although the same neuropathologic abnormalities of dendritic spines have been reported in both human and mouse (Hinton et al., 1991; Comery et al., 1997; Irwin et al., 2001).”
BackgroundThe fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif
Schaeffer, C., Bardoni, B., Mandel, J., Ehresmann, B., Ehresmann, C., & Moine, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4803 · Cited by 471 · cited 2×
“It binds to 4% of human fetal brain mRNA, to myelin basic protein mRNA and a specific binding was demonstrated to its own mRNA (Ashley et al., 1993a; Brown et al., 1998; Schaeffer et al., 2001).”
BackgroundEberhart, D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1083 · Cited by 390
Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice.
Wu, Z. L., Thomas, S. A., Villacres, E. C., Xia, Z., Simmons, M. L., Chavkin, C., Palmiter, R. D., & Storm, D. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.220 · Cited by 370 · cited 2×
“…Genome Res 100:111–123 (2003) ies on other, unrelated knockout mouse models have shown that also long-term potentiation (LTP) is involved in malperformance of the Morris water maze task (Grant et al., 1992; Silva et al., 1992a, 1992b; Bach et al., 1995; Sakimura et al., 1995; Wu et al., 1995).”
BackgroundAdult fragile X syndrome: Clinico-neuropathologic findings
Rudelli, R. D., Brown, W. T., Wisniewski, K., Jenkins, E. C., Laure-Kamionowska, M., Connell, F., & Wisniewski, H. M. (1985) · Acta Neuropathologica · doi:10.1007/bf00687814 · Cited by 362
Translational Suppression by Trinucleotide Repeat Expansion at FMR1
Feng, Y., Zhang, F., Lokey, L. K., Chastain, J. L., Lakkis, L., Eberhart, D., & Warren, S. T. (1995) · Science · doi:10.1126/science.7732383 · Cited by 358
Fragile X mice develop sensory hyperreactivity to auditory stimuli
Chen, L., & Toth, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00036-7 · Cited by 345
Characterization and localization of the FMR-1 gene product associated with fragile X syndrome
Verheij, C., Bakker, C. E., de Graaff, E., Keulemans, J., Willemsen, R., Verkerk, A. J. M. H., Galjaard, H., Reuser, A. J. J., Hoogeveen, A. T., & Oostra, B. A. (1993) · Nature · doi:10.1038/363722a0 · Cited by 343 · cited 2×
“This methylation blocks the transcription of FMR1, and thus results in the absence of FMRP (Pieretti et al., 1991; Verheij et al., 1993).”
BackgroundSelf-citationSynaptic regulation of protein synthesis and the fragile X protein
Greenough, W. T., Klintsova, A. Y., Irwin, S. A., Galvez, R., Bates, K. E., & Weiler, I. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141145998 · Cited by 317
Paradee, W., Melikian, H. E., Rasmussen, D. L., Kenneson, A., Conn, P. J., & Warren, S. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00285-7 · Cited by 305 · cited 7×
“In addition, tests measuring exploration, hyperactivity, anxiety, conditioned fear and aggression were performed (Bakker et al., 1994; Kooy et al., 1996; D’Hooge et al., 1997; Paradee et al., 1999; Dobkin et al., 2000; Peier et al., 2000; Van Dam et al., 2000; Mineur et al., 2002).”
BackgroundMethodInfluentialAudiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome
Musumeci, S. A., Bosco, P., Calabrese, G., Bakker, C., De Sarro, G. B., Elia, M., Ferri, R., & Oostra, B. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01499.x · Cited by 289
Self-citation(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Peier, A. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1145 · Cited by 285
The fragile X mental retardation protein is associated with ribosomes
Khandjian, E. W., Corbin, F., Woerly, S., & Rousseau, F. (1996) · Nature Genetics · doi:10.1038/ng0196-91 · Cited by 251 · cited 1×
“FMRP was found associated with ribosomes in the cell body and in dendrites (Eberhart et al., 1996; Khandjian et al., 1996; Tamanini et al., 1996; Corbin et al., 1997; Feng et al., 1997; Weiler et al., 1997).”
BackgroundNeurodevelopmental effects of the FMR-1 full mutation in humans
Reiss, A. L., Abrams, M. T., Greenlaw, R., Freund, L., & Denckla, M. B. (1995) · Nature Medicine · doi:10.1038/nm0295-159 · Cited by 242
Chiurazzi, P., Grazia Pomponi, M., Pietrobono, R., Bakker, C. E., Neri, G., & Oostra, B. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2317 · Cited by 217
Self-citationBehavioral and neuroanatomical characterization of the Fmr1 knockout mouse
Mineur, Y. S., Sluyter, F., de Wit, S., Oostra, B. A., & Crusio, W. E. (2002) · Hippocampus · doi:10.1002/hipo.10005 · Cited by 216
Mildly impaired water maze performance in maleFmr1 knockout mice
D'Hooge, R., Nagels, G., Franck, F., Bakker, C. E., Reyniers, E., Storm, K., Kooy, R. F., Oostra, B. A., Willems, P. J., & De Deyn, P. P. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00224-2 · Cited by 208 · cited 3×
“In addition, tests measuring exploration, hyperactivity, anxiety, conditioned fear and aggression were performed (Bakker et al., 1994; Kooy et al., 1996; D’Hooge et al., 1997; Paradee et al., 1999; Dobkin et al., 2000; Peier et al., 2000; Van Dam et al., 2000; Mineur et al., 2002).”
BackgroundMethodSelf-citationIn Vitro Reactivation of the FMR1 Gene Involved in Fragile X Syndrome
Chiurazzi, P., Pomponi, M. G., Willemsen, R., Oostra, B. A., & Neri, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.109 · Cited by 198
Self-citationSittler, A., Devys, D., Weber, C., & Mandel, J.-L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.95 · Cited by 198
Characterization of the full fragile X syndrome mutation in fetal gametes
Malter, H. E., Iber, J. C., Willemsen, R., Graaff, E. D., Tarleton, J. C., Leisti, J., Warren, S. T., & Oostra, B. A. (1997) · Nature Genetics · doi:10.1038/ng0297-165 · Cited by 197
Self-citationFmr1 knockout mouse has a distinctive strain-specific learning impairment
Dobkin, C., Rabe, A., Dumas, R., El Idrissi, A., Haubenstock, H., & Ted Brown, W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00292-x · Cited by 179
Cyclic AMP metabolism in fragile X syndrome
Berry‐Kravis, E., & Huttenlocher, P. R. (1992) · Annals of Neurology · doi:10.1002/ana.410310105 · Cited by 81 · cited 2×
“Biochemical abnormalities in human fragile X patients are limited to a lowered cyclic AMP production (Berry-Kravis and Huttenlocher, 1992), and an increased mean corpuscular hemoglobin (MCH) level (Langenbeck et al.”
Background
Cited by
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Drosophila, the golden bug, emerges as a tool for human genetics
Bier, E. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1503 · Cited by 625
McBride, S. M. J., Choi, C. H., Wang, Y., Liebelt, D., Braunstein, E., Ferreiro, D., Sehgal, A., Siwicki, K. K., Dockendorff, T. C., Nguyen, H. T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.038 · Cited by 472
The molecular biology of FMRP: new insights into fragile X syndrome
Richter, J. D., & Zhao, X. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00432-0 · Cited by 390
Metadata
- Authors
- Bakker, C. E., & Oostra, B. A.
- Venue
- Cytogenetic and Genome Research
- Publisher
- S. Karger AG
- Published
- 2003
- Volume
- 100
- Issue
- 1-4
- Pages
- 111-123
- ISSN
- 1424-859X (ISSN-L)
- 1424-8581
- OpenAlex
- W2006602581
- Cited by
- 86
- References
- 39
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.